Precision BioSciences Inc (DTIL) Stock Analysis

Precision BioSciences Inc (DTIL) is a publicly traded company in the HEALTHCARE sector. It trades at $6.32, carries a market capitalization of $181.13M. This page summarizes the public market data, fundamentals, and frequently asked questions for DTIL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.32
• Market Cap: $181.13M
• EPS: $-2.17
• 52-Week High: $8.82
• 52-Week Low: $3.53

Market Sentiment

Precision BioSciences Inc currently has a Bullish sentiment score of 0.42.

About Precision BioSciences Inc

Precision BioSciences, Inc. (Ticker: DTIL) is a pioneering genome editing company based in Durham, North Carolina, renowned for its innovative therapeutic products aimed at treating a diverse array of diseases. Utilizing its proprietary ARCUS platform, the company excels in developing highly precise genetic therapies, with a strategic focus on oncology, genetic disorders, and infectious diseases. With a promising pipeline and a firm commitment to advancing genetic medicine, Precision BioScien...

GNG Research Analysis

GNG Research scores Precision BioSciences Inc (DTIL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DTIL.

Frequently Asked Questions

Does DTIL pay dividends?

Precision BioSciences Inc (DTIL) does not currently pay a regular dividend.

What is DTIL's market cap?

Precision BioSciences Inc (DTIL) has a market capitalization of $181.13M with a current stock price of $6.32.